A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Adolescents andadults Aged 13‐55 Years: A Phase III, Randomized, Double‐Blind, Active‐Controlled Study
Epistemonikos ID: 2a3c3c00e68618ea75000b3b9e32bcabdf721a9e
First added on: Oct 01, 2024